Ryan David Lake - 08 Jul 2021 Form 4 Insider Report for Recro Pharma, Inc.

Role
Chief Financial Officer
Signature
By: /s/ Ryan D. Lake
Issuer symbol
N/A
Transactions as of
08 Jul 2021
Net transactions value
-$10,137
Form type
4
Filing time
13 Jul 2021, 06:03:55 UTC
Previous filing
08 Jun 2021
Next filing
16 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Tax liability $10,137 -5,172 -1.4% $1.96 373,173 08 Jul 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were withheld by the Issuer to satisfy applicable withholding taxes upon vesting of restricted stock units.